STD Diagnostics Market Research Analysis 2024-2033 | Growth, Size, Demand, Analysis, Insights

STD Diagnostics Market
Spread the love

Overview and Scope

STDs (sexually transmitted diseases) diagnostics refers to analyzing and identifying infectious illnesses spread by sexual contact from an infected person to a healthy person. STD diagnostics are used to detect whether an individual has been infected with sexually transmitted diseases.

Sizing and Forecast

The std diagnostics market size has grown rapidly in recent years. It will grow from $9.25  billion in 2023 to $10.19  billion in 2024 at a compound annual growth rate (CAGR) of 10.1%.  The  growth in the historic period can be attributed to epidemiological trends, healthcare infrastructure development, pharmaceutical developments, sexual education programs, demographic shifts..

The std diagnostics market size is expected to see strong growth in the next few years. It will grow to $14.82  billion in 2028 at a compound annual growth rate (CAGR) of 9.8%.  The growth in the forecast period can be attributed to personalized medicine trends, healthcare access improvements, population health strategies, telemedicine and digital health, rising incidence of stds.. Major trends in the forecast period include point-of-care testing (poct) advancements, home testing kits,multiplex testing, targeted marketing and outreach, pre-exposure prophylaxis (prep) programs, rising incidence rates..

 To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report

Segmentation & Regional Insights

The std diagnostics market covered in this report is segmented –

1) By Type: Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing, Other Types

2) By Location Of Testing: Laboratory Testing, Point Of Care (PoC) Testing

3) By End-User: Hospitals And Clinics, Diagnostic Centers, Homecare

North America was the largest region in the STD diagnostics market share in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the std diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report
https://www.thebusinessresearchcompany.com/sample.aspx?id=8507&type=smp

Major Driver Impacting Market Growth

The growing prevalence of STDs is driving the STD diagnostics market forward. STDs (sexually transmitted diseases) are infectious diseases that are transmitted from an infected person to a normal person through sexual contact. The STD diagnostics provide an efficient analysis and testing of this infection. For instance, in 2022, according to the World Health Organization (WHO), an international agency of the United Nations focusing on improving international public health, more than 1 million sexually transmitted infections are acquired every day globally. In addition, there are about 374 million new infections each year, with 1 of 4 STDs, chlamydia, gonorrhea, syphilis, and trichomoniasis. As a result, the rising prevalence of STDs propels the STD diagnostics market.

Key Industry Players

Major companies operating in the std diagnostics market report are Siemens AG, Abbott Laboratories, Qiagen Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Bio-Rad Laboratories Inc., Becton Dickinson and Company, Thermo Fisher Scientific Inc., Biocartis NV, Trinity Biotech plc, Binx Health Inc., Lybrate Inc., NOWDiagnostics Inc., Alere Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, BioMérieux SA, Chembio Diagnostic Systems Inc., Corgenix Medical Corporation, Creative Diagnostics, Curetis AG, Daktari Diagnostics, Enzo Biochem Inc., Fujirebio Diagnostics Inc., GenePOC Inc., GenMark Diagnostics Inc., Grifols Diagnostic Solutions Inc., Hain Lifescience GmbH, InDevR Inc., Inflammatix Inc., Karius Inc., Luminex Corporation, Meridian Bioscience Inc., Mesa Biotech Inc., Mobidiag Oy

The std diagnostics market report table of contents includes:

1. Executive Summary
2. STD Diagnostics Market Characteristics
3. STD Diagnostics Market Trends And Strategies
4. STD Diagnostics Market – Macro Economic Scenario
5.Global STD Diagnostics Market Size and Growth

31. Global STD Diagnostics Market Competitive Benchmarking
32. Global STD Diagnostics Market Competitive Dashboard
33. Key Mergers And Acquisitions In The STD Diagnostics Market
34.STD Diagnostics Market Future Outlook and Potential Analysis
35. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

 


Spread the love

About Top PR News

TopPRnews Leads Drives Search Engine Visibility For Your Press Release Content. Our Global Network Reaches Important Contacts, Media Partners And Websites And Journalists. Happy Postings! If You Have Any Queries Please Contact Official Mail At [[email protected]}

View all posts by Top PR News →